D.Western Therapeutics Institute, Inc. Logo

D.Western Therapeutics Institute, Inc.

Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.

4576 | T

Overview

Corporate Details

ISIN(s):
JP3548740004
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目18番11号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D.Western Therapeutics Institute, Inc. is a university-originated biotechnology venture focused on drug discovery and development. The company aims to create innovative and more effective drugs for patients worldwide by leveraging its core technology, which includes a proprietary compound library and specialized expertise in inhibitors, particularly protein kinases. Its business model centers on discovering and developing novel drug candidates before out-licensing them to larger pharmaceutical companies for late-stage clinical trials and commercialization. The company's development pipeline includes therapeutic drugs for various conditions, with a known focus in areas such as ophthalmology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:45
Interim Report
半期報告書-第28期(2025/01/01-2025/12/31)
Japanese 175.2 KB
2025-08-14 08:45
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-07-15 08:30
Registration Form
有価証券届出書(組込方式)
Japanese 540.8 KB
2025-03-26 01:26
Post-Annual General Meeting Information
臨時報告書
Japanese 25.8 KB
2025-03-25 07:31
Registration Form
確認書
Japanese 8.2 KB
2025-03-25 07:30
Governance Information
内部統制報告書-第27期(2024/01/01-2024/12/31)
Japanese 21.5 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第27期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-01-16 07:34
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-01-10 02:55
Major Shareholding Notification
臨時報告書
Japanese 21.1 KB
2024-08-09 08:35
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-08-09 08:34
Interim Report
半期報告書-第27期(2024/01/01-2024/12/31)
Japanese 219.2 KB
2024-06-07 08:31
Regulatory News Service
臨時報告書
Japanese 19.3 KB
2024-05-17 08:01
Registration Form
有価証券届出書(組込方式)
Japanese 328.7 KB
2024-05-13 08:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-05-13 08:31
Quarterly Report
四半期報告書-第27期第1四半期(2024/01/01-2024/03/31)
Japanese 135.5 KB

Automate Your Workflow. Get a real-time feed of all D.Western Therapeutics Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for D.Western Therapeutics Institute, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for D.Western Therapeutics Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan
7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan
9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece
INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland
INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea
216400
IQVIA HOLDINGS INC. Logo
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL
B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea
052770

Talk to a Data Expert

Have a question? We'll get back to you promptly.